Tyrosine kinase inhibitors: Can promising new therapy associated with cardiac toxicity strengthen the concept of teamwork?

Journal of Clinical Oncology

Volumn 26, Issue 32, 2008, Pages 5154-5155

  Lenihan, Daniel J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB;

CANCER THERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; COMORBIDITY; DRUG EFFICACY; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; PREVALENCE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARDIOVASCULAR DISEASES; HUMANS; INDOLES; NEOPLASMS; PATIENT CARE TEAM; PROTEIN KINASE INHIBITORS; PYRIDINES; PYRROLES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 55949101031     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.5439     Document Type: Editorial

References (17)

1. Chen MH, Kerkelä R, Force T: Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation 118:84-95, 2008
2. Schmidinger M, Zielinski CC, Vogl UM, et al: Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol doi:10.1200/JCO.2007.15.6331 [epub ahead of print on October 6, 2008]
3. Chu TF, Rupnick MA, Kerkela R, et al: Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 370:2011-2019, 2007
4. Khakoo AY, Kassiotis CM, Tannir N, et al: Heart failure associated with sunitinib malate: A multitargeted receptor tyrosine kinase inhibitor. Cancer 112:2500-2508, 2008
5. Pfizer: SUTENT (sunitinib malate) package insert. New York, NY, Pfizer, 2006
6. Bayer: NEXAVAR (sorafenib) package insert. Wayen, NJ, Bayer, 2005
7. Ewer MS, Lenihan DJ: Left ventricular ejection fraction and cardiotoxicity: Is our ear really to the ground? J Clin Oncol 26:1201-1203, 2008
8. Bhatia RS, Tu JV, Lee DS, et al: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260-269, 2006
9. Owan TE, Hodge DO, Herges RM, et al: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251-259, 2006
10. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, et al: Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol 25:4952-4960, 2007
11. Doyle JJ, Neugut AI, Jacobson JS, et al: Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study. J Clin Oncol 23:8597-8605, 2005
12. van Heeckeren WJ, Bhakta S, Ortiz J, et al: Promise of new vasculardisrupting agents balanced with cardiac toxicity: Is it time for oncologists to get to know their cardiologists? J Clin Oncol 24:1485-1488, 2006
13. Sarkiss MG, Yusuf SW, Warneke CL, et al: Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer 109:621-627, 2007
14. Ewer MS, Vooletich MT, Durand JB, et al: Reversibility of trastuzumabrelated cardiotoxicity: New insights based on clinical course and response to medical treatment. J Clin Oncol 23:7820-7826, 2005
15. Hunt SA, Abraham WT, Chin MH, et al: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) - Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 112:e154-e235, 2005
16. Sica DA: Angiogenesis inhibitors and hypertension: An emerging issue. J Clin Oncol 24:1329-1331, 2006
17. Maitland ML, Ratain MJ: Terminal ballistics of kinase inhibitors: There are no magic bullets. Ann Intern Med 145:702-703, 2006